Emergence of Haemophilus influenzae with low susceptibility to quinolones and persistence in tosufloxacin treatment

• Published in: Journal of global antimicrobial resistance. Vol. 18; pp. 104 - 108
• Main Authors: Tanaka, Emi, Hara, Naoki, Wajima, Takeaki, Ochiai, Shoko, Seyama, Shoji, Shirai, Atsuko, Shibata, Meiwa, Shiro, Hiroyuki, Natsume, Yoshiaki, Noguchi, Norihisa
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.09.2019
• Subjects: Multilocus sequence typing; Quinolone low-susceptible Haemophilus influenzae; Tosufloxacin; Tosufloxacin; Quinolone low-susceptible Haemophilus influenzae; Multilocus sequence typing
• ISSN: 2213-7165; 2213-7173
• DOI: 10.1016/j.jgar.2019.01.017

•Haemophilus influenzae has shown multidrug low susceptibility in recent years.•Quinolone low-susceptible Haemophilus influenzae isolates have emerged after introduction of tosufloxacin in the paediatric field.•Quinolone low-susceptible isolates might persist in tosufloxacin treatment, although they were judged as ‘susceptible’ to quinolones. The use of non-β-lactam agents has increased in Japan due to the prevalence of β-lactam-resistant pathogens. This study aimed to clarify the recent trend of antimicrobial susceptibility and molecular epidemiological features in Haemophilus influenzae. Fifty-seven Haemophilus influenzae isolated from a Japanese teaching hospital in 2017 were characterised, and the data were compared with those of a previous study. The MICs were determined using the broth dilution method. Genetic backgrounds were compared by multilocus sequence typing. The bactericidal activity of tosufloxacin at, or near, the therapeutic Cmax was determined in vitro, with susceptible isolates and quinolone low-susceptible isolates by time-kill assay. The results of the susceptibility tests showed that >90% of isolates were susceptible to cephalosporins and carbapenems, whereas ampicillin-susceptible and clarithromycin-susceptible isolates decreased. Regarding quinolones, low-susceptible isolates were noted in 2017, although all isolates were judged as susceptible. All low-susceptible isolates had an amino acid substitution in GyrA, and two isolates had an additional substitution in ParC. These isolates had different genetic backgrounds. Furthermore, the time-kill kinetic assay using the Cmax of tosufloxacin indicated that the low-susceptible isolates could persist for at least 8hours. This study revealed that Haemophilus influenzae has demonstrated multidrug low-susceptibility in recent years. The low-susceptible isolates had genetic diversity, meaning that resistance occurred independently.